Pancreatic nodal metastases: Biologic significance and therapeutic considerations

C. J. Yeo, J. L. Cameron

Research output: Contribution to journalReview articlepeer-review

Abstract

Adenocarcinomas of the pancreas remains a disease in which the majority of patients succumb to the neoplastic process, even after potentially curative resection. There has been an overall improvement in patient outcome in recent years, partially explicable by the increasing safety of pancreaticoduodenal resection. Factors have been identified as being important in long-term survival include diploid tumor DNA content, small tumor size, absence of lymph node metastases, and resection with negative resection margins. Another factor that appears to favor long-term survival is the use of postoperative combined modality chemoradiation therapy. Clearly, newer treatment modalities should be evaluated in the hope of improving outcome. Additionally, developments in earlier detection and staging, via applications from the field of molecular genetics, may provide further improvements in outcome.

Original languageEnglish (US)
Pages (from-to)145-157
Number of pages13
JournalSurgical Oncology Clinics of North America
Volume5
Issue number1
DOIs
StatePublished - 1996

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Pancreatic nodal metastases: Biologic significance and therapeutic considerations'. Together they form a unique fingerprint.

Cite this